Ukraine Keeps up Assault on Russian Oil Sites as Kyiv Expects More Strikes

Servicemen of the 13th Khartiia Brigade of the National Guard of Ukraine take part in a tactical training exercise on a shooting range at an undisclosed location in the Kharkiv region, northeastern Ukraine, 29 May 2026, amid the Russian invasion. (EPA)
Servicemen of the 13th Khartiia Brigade of the National Guard of Ukraine take part in a tactical training exercise on a shooting range at an undisclosed location in the Kharkiv region, northeastern Ukraine, 29 May 2026, amid the Russian invasion. (EPA)
TT

Ukraine Keeps up Assault on Russian Oil Sites as Kyiv Expects More Strikes

Servicemen of the 13th Khartiia Brigade of the National Guard of Ukraine take part in a tactical training exercise on a shooting range at an undisclosed location in the Kharkiv region, northeastern Ukraine, 29 May 2026, amid the Russian invasion. (EPA)
Servicemen of the 13th Khartiia Brigade of the National Guard of Ukraine take part in a tactical training exercise on a shooting range at an undisclosed location in the Kharkiv region, northeastern Ukraine, 29 May 2026, amid the Russian invasion. (EPA)

Ukrainian drone strikes caused fires at more Russian oil facilities overnight into Saturday, Russian officials said, in what appeared to be the latest attack on Moscow’s vital oil industry. 

Authorities in Russia’s Rostov region said falling drone debris sparked a fire that damaged an oil depot and tanker in the port of Taganrog, while officials in the neighboring Krasnodar region reported a fire breaking out at an oil depot in Armavir for the same reason. 

“Another facility of Russia’s oil industry has been reached — Armavir,” Ukrainian President Volodymyr Zelenskyy wrote on X, referring to the Krasnodar attack, and noting that Armavir is “500 kilometers from our state border.” 

“We are rightfully bringing the war back to where it came from,” he wrote. 

Ukraine has expanded its mid- and long-range strike capabilities, deploying drone and missile technology that it has developed domestically to battle Russia’s 4-year-old invasion. Attacks on Russian oil assets that play a key part in funding the invasion have become almost daily occurrences. 

For its part, Russia has used its long-range ballistic missiles to damage Ukraine’s power grid and hammer its cities. The Ukrainian capital is bracing for further heavy bombardments after what the Russian Foreign Ministry said earlier this week would be upcoming “systemic strikes” on Kyiv. 

Zelenskyy said Thursday that he’s being “very persistent” in pressing the United States to provide his country with more Patriot air defense missiles that can counter devastating Russian ballistic missile attacks. 

The attacks on Russian oil infrastructure came a day after a Russian drone that was part of an attack on Ukraine struck an apartment building in eastern Romania, injuring two people in the NATO member country. The incursion added to concerns that the war could spread across the alliance’s borders, and drew strong condemnation across Europe. 

Meanwhile, Russia’s state-owned nuclear energy company Rosatom said Saturday that a Ukrainian drone struck the Russian-controlled ‌Zaporizhzhia nuclear power plant. 

There was no damage to key equipment, but the attack left a hole in the wall of a turbine hall, Rosatom CEO Alexei Likhachev said. He was quoted as saying by Russian state media that the fact that the drone was controlled via fiber optics “completely rules out the possibility of an accidental impact.” 

Ukraine did not immediately comment on the incident. 

The plant is in an area under Russian control since early in Moscow’s full-scale invasion of Ukraine and is not in service, but it needs reliable power to cool its six shutdown reactors and spent fuel to avoid any catastrophic nuclear incidents. 

The International Atomic Energy Agency has repeatedly expressed alarm about the nuclear plant, Europe’s biggest. 



Türkiye’s Erdogan Distances Govt from Main Opposition Crisis, Warns Against Unrest

30 October 2025, Türkiye, Ankara: Recep Tayyip Erdogan, President of Türkiye, speaks at the press conference with German Chancellor Friedrich Merz after talks at the presidential palace. (dpa)
30 October 2025, Türkiye, Ankara: Recep Tayyip Erdogan, President of Türkiye, speaks at the press conference with German Chancellor Friedrich Merz after talks at the presidential palace. (dpa)
TT

Türkiye’s Erdogan Distances Govt from Main Opposition Crisis, Warns Against Unrest

30 October 2025, Türkiye, Ankara: Recep Tayyip Erdogan, President of Türkiye, speaks at the press conference with German Chancellor Friedrich Merz after talks at the presidential palace. (dpa)
30 October 2025, Türkiye, Ankara: Recep Tayyip Erdogan, President of Türkiye, speaks at the press conference with German Chancellor Friedrich Merz after talks at the presidential palace. (dpa)

President Recep Tayyip Erdogan said on Monday that the government would not be drawn into disputes within Türkiye's main opposition CHP and would not allow unrest on the streets, in ‌his first ‌public comments ‌since ⁠a court ruling last ⁠month annulled the party's 2023 congress and removed its leadership.

The court ruling effectively reinstated former CHP ⁠chairman Kemal Kilicdaroglu, a divisive ‌figure ‌within the party who ‌lost a presidential election ‌to Erdogan in 2023.

Speaking after a cabinet meeting in Ankara, Erdogan said ‌the government had no part in a ⁠political ⁠and legal struggle that had "spilled from party congress halls into court corridors" and would not allow "the streets to be thrown into turmoil" or the public to be pitted against security forces.


Mandelson Documents Cast Light on Government Work, Appointment of US Ambassador

Former UK ambassador to the United States, Peter Mandelson, is pictured as he walks his dog near his residence in central London on April 20, 2026. (AFP)
Former UK ambassador to the United States, Peter Mandelson, is pictured as he walks his dog near his residence in central London on April 20, 2026. (AFP)
TT

Mandelson Documents Cast Light on Government Work, Appointment of US Ambassador

Former UK ambassador to the United States, Peter Mandelson, is pictured as he walks his dog near his residence in central London on April 20, 2026. (AFP)
Former UK ambassador to the United States, Peter Mandelson, is pictured as he walks his dog near his residence in central London on April 20, 2026. (AFP)

Britain's government released reams of documents on Monday relating to the appointment of Peter Mandelson as ambassador to the United States, offering a glimpse into the often acerbic world of Westminster and his messy clearance for the job.

The Mandelson saga, which forced the departure of Prime Minister Keir Starmer's closest aide, has become a focus for criticism of Britain's prime minister, who is fighting for his political survival against a probable leadership challenge.

In a 1,504-page document, the government released messages — ranging from vetting emails to personal WhatsApps — in a data dump it hopes will take some of the focus off Starmer and show that ‌Mandelson was ‌less than frank over his ties to the late convicted sex ‌offender ⁠Jeffrey Epstein.

MANDELSON: 'YOU WILL ⁠NEVER REGRET' THE APPOINTMENT

In one document, the government said it had written to Mandelson on March 31 to request any information held on his personal phone as part of an investigation into his appointment and work - something he had declined to hand over.

Private messages from Mandelson - who was twice sacked from cabinet under Labour's longest-serving prime minister, Tony Blair - show him regularly chatting to Labour insiders, pressing his case and sometimes exchanging criticisms of ⁠the government.

In a handwritten note to then-foreign minister David Lammy on ‌November 18, 2024, Mandelson writes: "I just wanted you ‌to know that if you were minded to appoint me (as ambassador), I would make sure you ‌never regret it."

He also said he went "tonto" over the government's failure to immediately approve ‌a personalized red ministerial box as a gift to US President Donald Trump, using a slang term for going crazy.

He also took a swipe at Starmer, telling senior minister Pat McFadden he believed "Keir is not leading from the front".

In the same exchange, McFadden told Mandelson the government was "asking ‌the wrong questions", saying that every meeting was about "who can we tax in order to pay benefits to others".

The government ⁠hopes the release ⁠of the documents and his messages will put an end to questions surrounding Starmer's judgment in appointing a man whose friendship with Epstein was known. But they are unlikely to silence calls for the prime minister to stand down after Labour lost in local elections last month.

Mandelson is under police investigation for allegedly leaking government documents to the late Epstein. He does not face allegations of sexual misconduct.

An initial tranche of documents was released in March, which showed Starmer was warned of the risks of the appointment, not just over Mandelson's ties to Epstein but also because of the Labour veteran's support for closer ties with China.

Starmer now faces a possible leadership challenge later this year, if his main rival, Greater Manchester mayor Andy Burnham, wins a seat in parliament in an election on June 18.


‘We Need to Act Now’: Race to Develop Ebola Vaccine Heats Up

Health workers receive boxes of tents at the Evangelical Medical Center, one of the facilities at the forefront of the response to the Ebola outbreak, as agencies intensify efforts to contain a new Ebola outbreak caused by the Bundibugyo virus strain, in Bunia, Ituri province, Democratic Republic of Congo, May 31, 2026. (Reuters)
Health workers receive boxes of tents at the Evangelical Medical Center, one of the facilities at the forefront of the response to the Ebola outbreak, as agencies intensify efforts to contain a new Ebola outbreak caused by the Bundibugyo virus strain, in Bunia, Ituri province, Democratic Republic of Congo, May 31, 2026. (Reuters)
TT

‘We Need to Act Now’: Race to Develop Ebola Vaccine Heats Up

Health workers receive boxes of tents at the Evangelical Medical Center, one of the facilities at the forefront of the response to the Ebola outbreak, as agencies intensify efforts to contain a new Ebola outbreak caused by the Bundibugyo virus strain, in Bunia, Ituri province, Democratic Republic of Congo, May 31, 2026. (Reuters)
Health workers receive boxes of tents at the Evangelical Medical Center, one of the facilities at the forefront of the response to the Ebola outbreak, as agencies intensify efforts to contain a new Ebola outbreak caused by the Bundibugyo virus strain, in Bunia, Ituri province, Democratic Republic of Congo, May 31, 2026. (Reuters)

Several non-profit organizations announced Monday they are ramping up efforts to rapidly develop a vaccine for the rare strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo.

Nearly 250 people are suspected to have died and more than 1,100 infected with the strain in the DRC and neighboring Uganda, though the true spread of the virus is feared to be much wider.

While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no approved vaccines or treatments.

The escalating nature of the outbreak has sparked a race to find a vaccine that can be quickly developed, manufactured then tested in humans during clinical trials in the affected region.

The World Health Organization said on Saturday that its experts had determined "the most promising candidate vaccine" was a single-dose shot using the rVSV platform.

The only licensed Ebola vaccine, which targets the more common Zaire strain, uses the same platform.

The non-profit International AIDS Vaccine Initiative (IAVI) announced Monday it had reached a deal with the University of Texas Medical Branch to develop the rVSV candidate.

The university's Thomas Geisbert led work on both the Bundibugyo candidate and the licensed Zaire jab.

Geisbert told AFP last month that 2013 research demonstrated his jab provided very strong protection against Bundibugyo in monkeys.

However the vaccine "just sat there" for more than a decade because of a lack of interest, in particular from pharmaceutical firms, the virologist added.

The WHO estimated it would take seven to nine months before the rVSV vaccine is ready to be tested in humans.

- 'Fast-track' -

Also on Monday, the Coalition for Epidemic Preparedness Innovations (CEPI) announced funding to "fast-track" development of three Bundibugyo vaccine candidates, including $3.2 million towards the rVSV jab.

WHO chief Tedros Adhanom Ghebreyesus, who visited the epicenter of the outbreak in the DRC on the weekend, said in a statement the funding was "an important step forward".

Another vaccine candidate receiving CEPI funding was developed on the University of Oxford's ChAdOx1 platform, which also underpinned AstraZeneca's Covid vaccine.

This viral vector jab -- which will be manufactured by the huge Serum Institute of India -- could become available for clinical trials within two to three months, the WHO said.

CEPI also said it had committed $50 million to a vaccine candidate being developed by US pharma giant Moderna which uses the mRNA technology pioneered in its Covid vaccine.

In a preprint paper published online last week, researchers at France's INSERM institute called for trials to see if the licensed Zaire vaccine could also help fight Bundibugyo.

- $50 million pledge -

Also on Monday, the Gavi vaccine alliance announced it would make up to $50 million available for Bundibugyo vaccine efforts.

"We need to act now to ensure that, once one or more vaccine candidates are ready, manufacturers are in a position to start producing doses at scale," Gavi CEO Sania Nishtar said in a statement.

IAVI president Mark Feinberg told a press conference on Monday that Gavi's new commitment could fund the production of roughly 500,000 doses.

It also provided a "signal to manufacturers they can make this investment and not carry excessive risk," he added.

Even once doses for a trial are ready, there will be challenges in deploying them in a vast, remote area of the DRC that is already suffering crises including hunger, malaria and conflict.

Gaining the trust of communities where vaccines will be trialed will be crucial, the WHO emphasized.

And once a trial is finally carried out, there is no guarantee it will demonstrate the vaccine works.

"We have reasons to believe that we can generate effective vaccines, but we don't want to downplay at all that we have to treat them as investigational products," CEPI CEO Richard Hatchett said last week.

There are also several efforts to quickly trial several Bundibugyo treatments, including antivirals called remdesivir and obeldesivir, and the monoclonal antibody MBP134.